Market Scenario
Delirium is a neurological (nervous system) condition and a serious disturbance in mental abilities that causes mental confusion and emotional disruption. Delirium can be caused due to various factors such as older age, exposure to certain medications, alcohol abuse, surgery or other medical procedures, factors such as exposure to toxic or infectious agents, physical trauma, diet, and behavioral and occupational factors. The global delirium market is majorly driven by the increasing prevalence of neurological disorders and increasing older population leading to rise in patient population. Additionally, increasing government initiatives, increasing programs to create awareness, and market players offering advanced products are likely to drive the market. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5850 According to the United Nations, in 2017 approximately over 962 million population was aged over 60 and above globally. United Nations has also estimated that by 2050, the number of older population is likely to reach 425 million. This rising aging population is likely to propel the growth of global delirium market. Lack of awareness regarding the treatment is likely to hamper the growth of the market. The Global Delirium Market size is expected to grow at a CAGR of 6% during the forecast period. Segments The global delirium market is segmented on the basis of type, treatment, diagnosis, and end-user. On the basis of type, the market is segmented into hyperactive, hypoactive, and mixed. On the basis of diagnosis, the market is segmented into laboratory tests, imaging tests, and physical examination. On the basis of laboratory tests, it is further sub-segmented into blood tests and urine tests. On the basis of imaging tests, it is further sub-segmented into brain-imaging tests. On the basis of treatment, the market is segmented into antipsychotics and supportive care. On the basis of treatment, antipsychotics is further sub-segmented into risperidone, olanzapine, and quetiapine. On the basis of end-user, the market is segmented into specialty centers, hospitals, and research centers. Regional Analysis The North American delirium market is a growing market. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. The increasing prevalence of delirium affected the population, along with the increasing older population is likely to drive the market. Additionally, the growing healthcare infrastructure along with the increasing government support is likely to enhance the growth of delirium market in North America. For instance, according to the National Institute of Mental Health, in 2016, around 6.75 of adults in the U.S. were reported to have undergone depression. Europe is the second largest market and holds a healthy share in the global delirium market. The European market is expected to grow at a strong growth rate during the forecast period owing to the accessibility of advanced treatment facilities and rising skilled medical professionals along with the growing need for better healthcare set-up. Furthermore, the increasing older population, along with growing inclination towards sedentary lifestyle are driving the growth of the delirium market. Asia Pacific is expected to be the fastest growing market. The increasing prevalence of chronic diseases and infections is the major driver for the market growth. China is the fastest growing region owing to an increasingly older population and rising patient population. The increasing awareness regarding health and availability of new treatment methods drives the market in this region. The increasing healthcare expenditure and rise in the standard of living are driving the growth of the delirium market in the Asia Pacific region. The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the rise in healthcare development and rising demand for availability of specialty care centers. Key Players Some of the key players in the Delirium market are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/delirium-market-5850 About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected]
0 Comments
Market Synopsis
The cervix is the lower part of the uterus that connects to the vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, play a role in causing most of the cervical cancers. The disease begins when healthy cells acquire mutation leading to the uncontrolled growth of cells. These cells form a tumor which invades the nearby tissues. Squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas are three types of cervical cancers. Squamous cell carcinomas develop from cells in the exocervix while adenocarcinomas develop from gland cells. The cancer cells are said to have features of squamous cells under the microscope. Adenosquamous carcinomas feature both squamous cell carcinomas and adenocarcinomas. Cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, and trachelectomy are various treatment options for cervical cancer. Cystoscopy, proctoscopy, examination under anesthesia, and imaging studies such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), intravenous urography, and Positron Emission Tomography (PET scan) are used of the diagnosis of cervical cancer. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5834 The cervical cancer treatment market is mainly driven by the increasing prevalence of cervical cancer and increasing awareness about cervical cancer among women. Furthermore, the increasing demand for early diagnosis and treatment of cervical cancer is also expected to fuel the growth of the market during the review period. However, the high cost of treatment also fuels the growth of the market. The World Health Organization (WHO) stated that cancer was the leading cause of the total number of deaths globally in 2015 and was responsible for 8.8 million deaths. Key Players in the Global Cervical Cancer Treatment Market Some of the Cervical Cancer Treatment Market key players in this market are Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, ALLERGAN, Actavis Pharma Company, Eli Lilly and Company, Alnylam Pharmaceuticals, Inc, Hetero, Biocon, Novartis, Genentech USA, and others. Global Cervical Cancer Treatment market is expected to grow at a CAGR of 6.5% during the forecast period. Segments The global cervical cancer treatment market is segmented on the basis of type, treatment, and end-user. On the basis of type, the market is segmented into squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas. On the basis of treatment, the market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, hormone therapy, and others. Surgery is further segmented into cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, trachelectomy, and others. Radiation Therapy is further segmented into external beam radiation and brachytherapy Chemotherapy is further segmented into cisplatin, carboplatin, paclitaxel, doxorubicin, gemcitabine, bevacizumab, and others. Targeted therapy is further segmented into bevacizumab and pazopanib. Hormone therapy is further segmented into oestrogen, progesterone, progestogens, and testosterone. On the basis of end-user, the market is segmented into cancer care centers, diagnostic centers, pharmacies, and others. Regional Analysis of the Global Cervical Cancer Treatment Market Globally, Americas is the largest market for cervical cancer treatment whose growth is attributed to technological advancements in the field of oncology, increasing prevalence of cervical cancer, and development of new imaging devices by key players in the market. In North America, the market is driven by the increasing awareness of causes and risk factors of cervical cancer and its treatment. In the U.S., the market is driven by the increasing importance of women healthcare and changing lifestyle of women. South America exhibits a steady growth in the cervical cancer treatment market. In the European countries, the growth of the market is attributed to a number of healthcare institutions offering treatment of cancer and huge investments in research and development activities by the U.K. and Germany. In Germany, the market is mainly driven by an increase in the use of new technological devices for the diagnosis and treatment of cancer. In Asia Pacific, the cervical cancer treatment market exhibits numerous growth opportunities due to rising awareness about cervical cancer and the increasing demand for cost-effective treatment solutions such as chemotherapy. Japan, China, and India are the largest contributors to the market growth where the market is driven by the increasing emphasis on cancer detection and treatment and the rising prevalence of cancer. Additionally, availability of skilled healthcare professionals in research also accelerates the growth of the market. The increasing government support of oncology research and women healthcare initiatives and the rapid growth of the healthcare imaging industry in India and China fuel the f=growth of the market in the regions. In the Middle East, Saudi Arabia and the United Arab Emirates (U.A.E.) are the largest contributors to the market growth due to the focus on the development of new healthcare facilities catering to the needs of cancer patients and availability of technologically advanced diagnostic devices of management. In African countries, the increasing number of healthcare initiatives for women health and improvement in healthcare infrastructure are likely to boost the growth of the market. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cervical-cancer-treatment-market-5834 About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Market Scenario
Bone metastasis is characterized by the spreading of cancerous cells from their original site to a bone. All types of cancer can show bone-metastasis. However, it is estimated that breast cancer and prostate cancer are commonly associated with the disease. The medical condition is frequent for spine, pelvis, and thighs. Urinary incontinence, bowel incontinence, and hypercalcemia are some of the common symptoms of the disease. The increasing prevalence of bone metastasis is expected to be a major driver for the market growth during the forecast period. According to a study published in the Oncology Reviews Journal in 2017, the relative occurrence of bone metastasis was estimated to be around 65 to 75% for both breast and prostate cancers suffering patients, respectively. Moreover, the growing geriatric population, increasing healthcare expenditures, and increasing R&D in the market are estimated to drive the market growth during the forecast period. According to the American Society of Clinical Oncology in 2016, approximately 60% of the total cancer patients aged 65 years or more. However, factors such as lack of healthcare services in low-income countries, the high cost of treatment, and related side effects are estimated to restrain the market growth during the forecast period. According to a study published in the Journal of Spine Surgery in 2017, the mean total cost of therapeutic modalities such as vertebroplasty was estimated to be about USD 14,114 in 2014. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5776 The global bone metastasis market analysis is expected to grow at an approximate CAGR of 8.4% during the forecast period Intended Audience
The global bone metastasis market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of type, the market is segmented into osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis, and others. On the basis of diagnosis, the market is categorized into biopsy, blood test, imaging, and others. The imaging segment is sub-segmented into X-ray, bone scintigraphy, computerized tomography, magnetic resonance imaging, positron emission tomography, and others. On the basis of the treatment, the market is segmented into medical therapies, surgery, medication, and others. The medical therapies segment is sub-segmented into chemotherapy, targeted therapy, hormone therapy, ablation therapy, and others. The ablation therapy segment is further segmented into radiofrequency ablation, cryoablation, and others. The surgery segment is sub-segmented into vertebroplasty, kyphoplasty, and others. The medication segment is sub-segmented into pain medications, bone building medications, and others. The pain medication segment is sub-segmented into ibuprofen, morphine, and others. The bone-building medications segment is sub-segmented into corticosteroids, bisphosphonates, and others. The bisphosphonates segment is further segmented into teriparatide, pamidronate, medronate, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, pharmacies, and ambulatory surgical centers. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bone-metastasis-market-5776 About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Bronchitis is nothing but the inflammation of the lining of bronchial tubes of the lungs. It is of two types, namely, acute and chronic bronchitis. Acute bronchitis, also known as a chest cold, is found to be very common and develops from a cold or other respiratory infection. On the other hand, chronic bronchitis is a severe condition which is characterized by constant irritation or inflammation of the lining of bronchial tubes. It is included in the Chronic Obstructive Pulmonary Disease (COPD). Shortness of breath, cough, slight fever and chills, production of mucus, fatigue, and chest discomfort are major symptoms of bronchitis. It can be diagnosed through various tests such as chest X-ray, sputum tests, and pulmonary function test.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5758 The global bronchitis market is mainly driven by the increasing prevalence of lung diseases such as bronchitis, asthma, COPD, availability of drugs for the treatment, and drugs. Additionally, increasing number of diagnostic services for various chronic diseases and the use of technologically advanced devices for diagnosis also drive the growth of the market. Other factors supporting the market growth are an addiction to smoking and changing lifestyle. However, fierce competition among the existing market players restrains the growth of the market. The global bronchitis market size is expected to grow at a CAGR of 5.3% during the forecast period. Segments The global bronchitis market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of type, the market is segmented into acute bronchitis and chronic bronchitis. On the basis of diagnosis, the market is segmented into chest X-ray, sputum tests, and pulmonary function tests. On the basis of treatment, the market is segmented into drugs and oxygen therapy. Drugs is further segmented into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics. On the basis of end-user, the market is segmented into hospitals, clinics, pharmacies, research institutes, and others. Regional Analysis of the Global Bronchitis Market The American bronchitis market is segmented into two regions, namely, North America and South America. North America is the largest market with huge patient pool, growing awareness about bronchitis treatment among the people and presence of major players in the market. South America is expected to be the fastest growing market with the increasing demand for diagnostic services. In Europe, the bronchitis market is driven by the increasing focus on research and development activities for the treatment of chronic bronchitis. Germany and the U.K. occupy a first and second position in the European market which is driven by the increasing demand for diagnostic services for respiratory diseases and the emergence of new players in the market manufacturing various classes of drugs in the market. The bronchitis market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing environmental population, rising geriatric population with various respiratory diseases, and growing prevalence of lung diseases among the adults. Additionally, growth in the number of people addicted to smoking and increasing number of patients with COPD fuel the market in this region. The Middle Eastern and African market for bronchitis exhibits a steady rise with the growing awareness about causes, diagnosis, and treatment of chronic diseases. The demand for primary care services including diagnostic services for respiratory diseases fuels the market growth in Africa. Key Players in the Global Bronchitis Market Some of the key players in this market are GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Dr. Reddy’s Laboratories Ltd, Pfizer Inc., Sanofi, Cathay Drug Company Inc., Kaiser Permanente Inc., AstraZeneca, and others. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bronchitis-market-5758 About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Global substance abuse treatment market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 11.6% over the forecast period.
Substance abuse refers to the harmful use of psychoactive substances, including alcohol and illicit drugs. Increasing trends of cigarette smoking in teenagers is one of the prominent factors driving the Substance Abuse Treatment market. According to the 2015 study published in the Clinical and Translational Investigation journal, More than 60% of individuals start smoking at the age of 13 and more than 90% individuals start smoking before reaching 20 years. It is also reported that 5.8% of the Mexican population comprises adolescents between 13 and 15 years. Of them, 42.8% tried a cigarette at some point in their life. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7230 Various other factors such as increasing incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market. However, poor treatment compliance in some countries and reluctance of individuals for accessing treatment can hamper the market growth over the forecast period. Segmentation The global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region. The global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid. The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone. Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres. In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region. The substance abuse treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European substance abuse treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The substance abuse treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The substance abuse treatment market in the Middle East & Africa has been segmented into the Middle East and Africa. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Medication Management Market: Recent Industry Trends and Projected Industry Growth, 2020– 20274/26/2021 Market Scenario
The Global medication management market is expected to register a CAGR of 13.4% during the forecast period of 2018 to 2023. Medication management is a strategy which ensures that the patient understands the purpose of the medications and takes it in the correct manner at the correct time. It also focuses on improving the use of medications for the patient’s condition. Interventions may include medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient. Rising geriatric population is one of the key factors driving the medication management market. Older adults tend to have significant comorbidities which in result increase the medication use and escalate the risk of poor outcomes. According to a 2018 study published in the Clinical Epidemiology, in high income countries, polypharmacy affects between 40% and 50% of older adults. Polypharmacy increases the risk of adverse drug-related events in older adults because a higher number of drugs are associated with a higher risk of harmful drug–drug interactions. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7187 Various other factors such as rising healthcare IT funds, and need for reducing healthcare costs. However, high software implementation and service maintenance costs can hamper the market growth over the forecast period. Segmentation The Global medication management market is segmented based on systems, services, mode of delivery, end user and region. The global market for medication management, by systems is segmented into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems and assurance systems. The administration software is further classified as electronic medication administration records (eMAR) software and bar code medication administration (BCMA) software. The automated dispensing systems segment is further classified as centralized automated dispensing systems and decentralized automated dispensing systems (ADS). The centralized automated dispensing system includes robots/robotic automated dispensing systems and carousels. The decentralized automated dispensing system (ADS) includes pharmacy-based decentralized automated dispensing systems, ward-based decentralized automated dispensing systems and automated unit-dose decentralized automated dispensing systems. The market by services segment is divided into point-of-care verification services and adverse drug effects (ADE) surveillance services. The market by mode of delivery segment is divided into web-based solutions, on-premise solutions and cloud-based solutions. Based on end user, the market is segmented into hospitals, pharmacies and others In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region. The Medication management Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Medication management Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Medication management Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Medication management Market in the Middle East & Africa has been segmented into the Middle East and Africa. Regional Market Summary The Americas dominated the global market for medication management owing to increasing polypharmacy, presence of major market players and developed economies like US and Canada within the region. In 2017, BD launched its latest advancement in comprehensive medication management, BD HealthSight platform for enterprise medication management. The BD HealthSight platform connects systems and processes to help hospitals to drive a safer, more efficient medication management process. In 2017, it was estimated that Europe stood second in the global Medication Management market. This can be attributed to the presence of developed economies like UK, Germany, France, and others within the region boost the market growth. Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing government’s support for foreign investments drives the regional markets of the Asia Pacific region. According to a report published by the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to grow at a CAGR of 22.87% and reach USD 280 billion by 2020. On the other hand, the Middle East and Africa held least share in the global medication management market due to the presence of poor economies and low per capita income, especially within the African region. Key players Some of the key players in the global medication management market are Allscripts Healthcare 0Electric Company, Mckesson Corporation, Medical Information Technology, Inc., Omnicell, Inc., Optum Inc., QuadraMed Affinity Corporation, Siemens Ltd and others. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Market Snapshot:
MRFR reports that the clinical laboratory services market is likely to exhibit a sound growth rate during the forecast period (2018-2023). The global clinical laboratory services market is expected to surpass a valuation of USD 274,400 Million by 2023. Demand for clinical laboratory services is on the rise due to the increased healthcare expenditure coupled with growing awareness about such services. North America is a major region for these services and presents lucrative growth opportunities to market players. Moreover, existence of advanced healthcare infrastructure and widespread availability of lab experts and technicians is supplementing the growth of the clinical laboratory services market in North America. Meanwhile, APAC is also likely to remain under the investment radar of companies operating on a global level. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7145 Synopsis: MRFR in its latest report offers a detailed observation on the global clinical laboratory services market. It also includes a revenue analysis and market projection until 2023. All the important parameters are considered for analysis. In this report, the market element such impacting trends, drivers, opportunities and threats are thoroughly discussed. The scope of the discussion covers different types of clinical laboratory services such as biochemistry, microbiology, endocrinology, hematology, histopathology, cytology and genetic testing. Application areas considered for laboratory services are independent, laboratory, reference Laboratory and hospital laboratory. Report Coverage: Historical clinical laboratory services market trends, forecast, dynamics, value by region as well as by segmentation, country-level analysis for each segment, key player’s market share analysis and factor analysis which covers supply chain and Porter’s five forces analysis of the market. Companies Covered: Laboratory Corporation of America Holdings, Mayo Medical Laboratories, Spectra Laboratories Inc, Unilabs, Bio-Reference Laboratories, Clinical Reference Laboratory, Adicon Clinical Laboratory, Amedes Holdings, Lifelabs Medicals Laboratories, Quest Diagnostics Incorporated, Synlab International, ACM Medical Laboratory, Eurofins Scientific, Cerba Healthcare and Sonic Healthcare. Research Methodology: MRFR leverages its optimum statistical solution for assessment of critical elements to ensure the deliverance of in-depth clinical laboratory services market foresight. The multi-layered research module is utilized for qualitative and quantitative analysis of governing factors and macroeconomic indicators of the market such as current market dynamics, historical trends, consumer landscape, growth opportunities, and challenges. Primary and secondary research processes form the foundation of the research methodology utilized for prudent clinical laboratory services market analysis. The collected data is verified through inputs from surveys, personal interviews, research publications, paid databases, and other credible sources available in public domain. In addition, the top-down and bottom-up approaches are employed for authentication of research findings which are then verified using a strong data triangulation technique. Global Clinical Laboratory Services Market – Segmental Analysis: This MRFR report offers a detailed segmental analysis of the global clinical laboratory services market based on type and application. By type, the market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, genetic testing, and others. Among these, the hematology segment held 25.6% market share in 2017. It is estimated to retain its dominant position through the forecast period. The growth of the segment can be ascribed to the large-scale prevalence of blood cancer. As per the 2018 statistics revealed by the Leukemia & Lymphoma Society, around 60,300 people are projected to be diagnosed with leukemia, whereas, 24,370 people are expected to succumb to the disease. By application, the global clinical laboratory services market has been segmented into independent laboratory, reference laboratory, and hospital laboratory. Among these, the hospital laboratory segment is likely to dominate the global market over the assessment period. The valuation of the segment has been predicted to grow from USD 152,574 Mn in 2017 to USD 185,982 Mn by 2023-end. Factors such as the availability of different tests and favorable reimbursement policies for tests in the region are presumed to drive the growth of the clinical laboratory services market in the foreseeable future. Regional Outlook: By region, the global clinical laboratory services market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the maximum share of the market in 2017 and is forecasted to grow significantly over the next couple of years. The factors that are poised to aid the proliferation of the clinical laboratory services market in the region include favorable reimbursement policies, growth of clinical laboratories, and increasing count of lab technicians. It has been estimated that the valuation of the market will touch USD 108,913 Mn by the end of 2023. Europe is an important growth pocket forecasted to hold the second spot in the global marketplace. The competitive landscape of the market is growth inducive owing to the presence of major prominent key players, rising healthcare expenditure, rising count of clinical tests, etc. The Middle East & Africa is expected to reach a valuation of USD 14,067 Mn by 2023-end from USD 11,252 Mn in 2017. Asia Pacific is expected to emerge as the fastest growing regional market over the projection period. The region signifies strong growth opportunities for the expansion of the market. It is estimated to thrive at a CAGR of 5% during the forecast period. The rising burden of diseases such as cancer, diabetes, etc. is the driving force of market growth in the region. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Surgical Drapes and Gowns Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)4/26/2021 Market Scenario
Global surgical drapes and gowns market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.23 billion in 2017 and is projected to grow at a CAGR of 4.4% over the forecast period. The factors such as increasing number of surgeries and high incidences of hospital-acquired infections are expected to propel the growth of the market. However, reuse of surgical drapes and gowns in developing regions hamper the market growth over the forecast period. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7122 Segmentation The global surgical drapes and gowns market has been segmented into type, usage pattern, and end user. Based on type, surgical drapes and gowns market is segmented into surgical drapes and surgical gowns. The surgical drapes segment is expected to account for the largest share segment of the market in 2017. Based on usage pattern, surgical drapes and gowns market is segmented into disposable surgical drapes & gowns and reusable surgical drapes & gowns. Based on end user, surgical drapes and gowns market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest share segment of the market in 2017. The surgical drapes and gowns market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drapes and gowns market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada. The European surgical drapes and gowns market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The surgical drapes and gowns market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drapes and gowns market in the Middle East & Africa segmented into the Middle East and Africa. Key players Halyard Health (US), Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Thermo Fisher Scientific (US), STERIS Corporation (US), Paul Hartmann AG (Germany), Pacon Manufacturing (US), Medica Europe B.V. (The Netherlands), and Guardian (US) are some of the key players in the global surgical drapes and gowns market. Regional Market Summary Geographically, the Americas is anticipated to dominate the global surgical drapes and gowns market owing to a well-established player and increasing surgical procedures. Europe is expected to hold the second largest position in the global surgical drapes and gowns market. The market growth in this region is attributed to the growth in surgical procedures. The surgical drapes and gowns market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region. The Middle East & Africa has the least share of the surgical drapes and gowns market Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-drapes-and-gowns-market-7122 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] Market Scenario
The global surgical microscopes market is expected to grow significantly over the forecast period. The market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period. Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7065 On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent. Segmentation The global surgical microscopes market has been segmented into type, application and end user. Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products. Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment. Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period. Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada. European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa. Key players Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc. are some of the key players in the global surgical microscopes market. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected] |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |